670704AL9
Nuvasive Inc
Could not find a ticker for this position, may be a filing error
A maker of surgical technology for spine surgery, NuVasive builds implants, instruments, and nerve-monitoring systems that let surgeons operate on the spine through smaller incisions. Its signature XLIF procedure approaches the spine from the side of the body, sparing patients the heavy muscle cutting of traditional back surgery. Founded in 1997 in San Diego by orthopedic surgeon Jim Marino, the company's name blends "new" and "invasive" to signal a less disruptive way of doing invasive procedures. In 2023 it merged with Globus Medical.
CONVERTIBLEUnderlying: NUVACUSIP: 670704AL9HealthcareUS1 derivative reporter
1.00% convertible senior notes due 2023
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
